STOCK TITAN

NGVT insider filing to sell 3,700 restricted shares valued at $194.7K

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Ingevity Corporation (NGVT) Form 144 reports that insider Stuart E. Woodcock Jr. intends to sell 3,700 common shares on 08/11/2025 through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $194,662.55. The filing lists the securities as restricted stock that vested under a registered plan with acquisition dates of 02/27/2017, 02/27/2018 and 02/26/2020, and records a recent separate sale on 08/05/2025 of 6,720 shares for $323,904.00. Outstanding shares are shown as 36,466,285, so the planned sale represents a very small fraction of total common stock.

The notice includes the seller’s representation that they do not possess undisclosed material adverse information. The document otherwise provides routine Rule 144 disclosure details: broker, share counts, acquisition type, and prior recent sales by the same person.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Small insider sale of 3,700 shares (≈$194.7K); prior 6,720-share sale noted—transaction appears immaterial to NGVT equity.

The Form 144 shows a proposed sale of 3,700 shares valued at $194,662.55 to be executed on 08/11/2025 through Morgan Stanley Smith Barney on the NYSE. With 36,466,285 shares outstanding, the sale equals roughly 0.01% of the outstanding float, indicating no obvious market-moving size. The filing documents restricted shares that vested in 2017, 2018 and 2020 and notes a prior sale on 08/05/2025 of 6,720 shares for $323,904.00. Overall, this is standard insider liquidity activity disclosed per Rule 144.

TL;DR: Filing documents sales of vested restricted awards and reiterates the seller’s certification of no material nonpublic information.

The notice identifies the securities as restricted stock vesting under a registered plan, lists the acquisition dates, specifies the broker and exchange, and includes the statutory representation that the seller lacks material nonpublic information. Those elements align with compliance expectations under Rule 144 and Exchange Act trading-plan standards. The presence of a recent prior sale is disclosed, supporting transparency about insider dispositions. No governance irregularities or unexplained transfers are evident in the document.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the NGVT Form 144 filing report?

The filing reports that Stuart E. Woodcock Jr. intends to sell 3,700 common shares on 08/11/2025, valued at $194,662.55, via Morgan Stanley Smith Barney on the NYSE.

What type of shares are being sold according to the filing?

The securities are described as restricted stock that vested under a registered plan, with acquisition dates of 02/27/2017, 02/27/2018, and 02/26/2020.

Has the seller made recent sales of NGVT shares?

Yes. The filing records a prior sale on 08/05/2025 of 6,720 shares that generated $323,904.00 in gross proceeds.

How large is the proposed sale relative to NGVT's outstanding shares?

The filing lists 36,466,285 shares outstanding; the planned sale of 3,700 shares represents approximately 0.01% of outstanding common stock.

Which broker and exchange are identified for the sale?

The broker is Morgan Stanley Smith Barney LLC (Executive Financial Services, New York) and the exchange listed is the NYSE.
Ingevity Corp

NYSE:NGVT

NGVT Rankings

NGVT Latest News

NGVT Latest SEC Filings

NGVT Stock Data

2.41B
35.35M
1.21%
103.73%
2.04%
Specialty Chemicals
Chemicals & Allied Products
Link
United States
NORTH CHARLESTON